25Schools
University revision · Pharmacology II (Systemic Therapeutics)

Extrapyramidal Side Effects and Movement Disorders

This essential topic for tertiary health science students in Zambia examines the extrapyramidal side effects (EPS) associated with antipsychotic medications, including akathisia, dystonia, drug-induced parkinsonism, and tardive dyskinesia. It delves into the underlying neurochemical pathophysiology involving dopaminergic pathways in the basal ganglia. The content is critical for university and college learners in medicine and pharmacy to accurately diagnose, manage, and prevent these adverse drug reactions in clinical settings. Understanding these movement disorders is vital for patient safety, informed consent, and optimizing pharmacotherapy for psychiatric conditions. Mastery of this topic is assessed in professional and degree-level examinations and is a cornerstone of competent, ethical pharmacological practice in Zambia's tertiary healthcare education and beyond.

Questions
100
Est. time
~100 min
Views
0
Pass mark
50%

How this revision works

Outcomes

If you passWell done! You have successfully navigated the complex landscape of extrapyramidal side effects. Your ability to distinguish between different movement disorders and understand their management is a key competency for any future doctor or pharmacist in Zambia. This knowledge significantly enhances your clinical acumen.
If you don't pass yetUnderstanding EPS is challenging but crucial. Take time to differentiate the clinical features of akathisia, dystonia, parkinsonism, and tardive dyskinesia. Review the associated dopaminergic pathways and treatment strategies. Engaging in case-based discussions with peers can solidify these concepts for your tertiary exams and future practice.

More in this course